|
ATGP2842-250ug
|
NKMax Bio (ATGen)
|
CSK [1-450 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP2842-50ug
|
NKMax Bio (ATGen)
|
CSK [1-450 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
GTX42266
|
GeneTex International Corporation
|
Mannose Receptor [7-450], Mouse Monoclonal Antibody
|
Human
|
IHC-Fr
|
|
|
GTX42267
|
GeneTex International Corporation
|
Mannose Receptor [7-450], Mouse Monoclonal Antibody
|
Human
|
IHC-Fr
|
|
|
HY-125904-1mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-125904-5mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-104001-1mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-10mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-100mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-5mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-50mg
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6]
|
|
Cancer-programmed cell death
|
|
|
HY-104001-1mL
|
MedChemexpress LLC
|
BAY-524 [CAS 1445830-39-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138832-1mg
|
MedChemexpress LLC
|
BM-1244 [CAS 1619923-32-8]
|
|
Cancer-programmed cell death
|
|
|
HY-138832-10mg
|
MedChemexpress LLC
|
BM-1244 [CAS 1619923-32-8]
|
|
Cancer-programmed cell death
|
|
|
HY-138832-25mg
|
MedChemexpress LLC
|
BM-1244 [CAS 1619923-32-8]
|
|
Cancer-programmed cell death
|
|
|
HY-138832-5mg
|
MedChemexpress LLC
|
BM-1244 [CAS 1619923-32-8]
|
|
Cancer-programmed cell death
|
|
|
HY-N7131-10mg
|
MedChemexpress LLC
|
Coumarin 6 [CAS 38215-36-0]
|
|
|
|
|
HY-N7131-100mg
|
MedChemexpress LLC
|
Coumarin 6 [CAS 38215-36-0]
|
|
|
|
|
HY-N7131-5mg
|
MedChemexpress LLC
|
Coumarin 6 [CAS 38215-36-0]
|
|
|
|
|
HY-N7131-50mg
|
MedChemexpress LLC
|
Coumarin 6 [CAS 38215-36-0]
|
|
|
|
|
HY-N7131-1mL
|
MedChemexpress LLC
|
Coumarin 6 [CAS 38215-36-0] (10mM in DMSO)
|
|
|
|
|
HY-146808-10mg
|
MedChemexpress LLC
|
Galectin-3 antagonist 1 [CAS 2921603-03-2]
|
|
Cancer-programmed cell death
|
|
|
HY-146808-100mg
|
MedChemexpress LLC
|
Galectin-3 antagonist 1 [CAS 2921603-03-2]
|
|
Cancer-programmed cell death
|
|
|
HY-146808-25mg
|
MedChemexpress LLC
|
Galectin-3 antagonist 1 [CAS 2921603-03-2]
|
|
Cancer-programmed cell death
|
|
|
HY-146808-5mg
|
MedChemexpress LLC
|
Galectin-3 antagonist 1 [CAS 2921603-03-2]
|
|
Cancer-programmed cell death
|
|
